Objectives-Clinical and radiographic measures are gold standards for diagnosing periodontitis but offer little information regarding the pathogenesis of the disease. We hypothesized that a comparison of gene expression signatures between healthy and diseased gingival tissues would provide novel insights in the pathobiology of periodontitis, and would inform the design of future studies.
INTRODUCTION
A distinction between states of periodontal health and disease is feasible using a variety of diagnostic approaches. Among the common clinical variables, bleeding on probing (BoP) is considered to best reflect presence of an inflammatory infiltrate adjacent to the ulcerated epithelium of the periodontal pocket. 1, 2 . Probing depth (PD) exceeding the typical depth of the healthy gingival crevice, in presence of BoP, is also used to signify periodontal pathology, while clinical attachment loss (AL) describes the cumulative exposure to destructive periodontitis. 3 Loss of periodontal tissue support can also be assessed radiographically. 4 .
However, clinical and radiographic variables reflect poorly the underlying pathobiology of the various forms of periodontitis. The distinct histologic features of periodontal health and disease were first documented in a classic publication by Page and Schroeder. 5 These authors described the detailed morphologic characteristics of the gingival, sulcular, and pocket epithelium, the underlying connective tissue, and the types of resident and infiltrating blood cells in the initial, early, established and advanced periodontal lesion. In parallel, microbiologic approaches established common and distinct constituents of the periodontal microbiota in health and disease 6, 7 while biochemical approaches documented levels of cytokines, chemokines and other inflammatory mediators within the tissues and the gingival crevicular fluid. [8] [9] [10] A genomic tool that may add to the armamentarium of approaches to study the pathobiology of periodontitis is gene expression profiling, i.e., the systematic cataloging of messenger RNA sequences in a cell population, organ or tissue sample. In general, transcriptomes are a powerful means of generating comprehensive genome-level data sets on complex diseases and have provided enormous insights mostly in cancer research 11, 12 , but also in other conditions such as muscular dystrophy 13 , Alzheimer's disease and dementia 14, 15 , rheumatologic disorders 16, 17 , and asthma. 18, 19 To our knowledge, a systematic transcriptome-based approach has not been applied so far in the study of periodontitis. Our group has initiated a series of studies to explore whether the currently recognized forms of periodontitis are characterized by distinct gene expression profiles in affected gingival tissues. 20 Our further goal is to explore the feasibility of a novel classification based on similarities in transcriptional profiles. The aim of this first report is to present a comprehensive description of the periodontal transcriptome in healthy and diseased gingival tissues.
MATERIAL AND METHODS
The study was approved by the Columbia University Institutional Review Board.
Subjects
Ninety subjects with moderate to severe periodontitis (63 with chronic and 27 with aggressive periodontitis) were recruited among those referred to the Columbia University College of Dental Medicine between November 2004 and April 2007. Eligible patients were (i) >13 yrs old; (ii) had ≥ 24 teeth; (iii) had no history of systematic periodontal therapy other than occasional prophylaxis, (iv) had received no systemic antibiotics or anti-inflammatory drugs for ≥ 6 months, (v) harbored ≥4 teeth with radiographic bone loss, (vi) did not have diabetes or any systemic condition that entails a diagnosis of "Periodontitis as a manifestation of systemic diseases" 21 , (vii) were not pregnant, and (ix) were not current users of tobacco products or nicotine replacement medication. Signed informed consent was obtained prior to enrollment.
Clinical examination
All participants underwent a full-mouth examination of the periodontal tissues at six sites per tooth by a single, calibrated examiner. Variables recorded included presence/absence of visible dental plaque (PL), presence/absence of bleeding on probing (BoP), probing depth (PD), and attachment level (AL). Data were entered chair-side to a computer and stored at a central server.
Gingival tissue donor areas and tissue sample collection
Subsequently to clinical data entry, a specially developed software identified periodontally "diseased" and "healthy" tooth sites based on the clinical data. "Diseased" sites showed BoP, had interproximal PD>4mm, and concomitant AL≥3mm. "Healthy" sites showed no BoP, had PD≤4mm and AL≤2mm. Next, the software identified (i) maxillary "diseased" and "healthy" interdental papillae, based on the above criteria, and (ii) pairs of diseased interdental papillae with similar clinical presentation (PD and AL within 2mm of each other). A posterior maxillary sextant encompassing a pair of qualifying "diseased" interdental papillae was identified.
Periodontal surgery was performed at the identified sextant with no prior supra-or subgingival instrumentation. After local anesthesia, submarginal incisions were performed, mucoperiosteal flaps were reflected, and the portion of each interproximal gingival papilla that adhered to the root surface was carefully dissected. This section comprised the ulcerated epithelial lining of the interproximal periodontal pockets and the underlying connective tissue. After dissection, the gingival tissue specimens were thoroughly rinsed with sterile normal saline solution and transferred into Eppendorf tubes containing a liquid RNA stabilization reagent * . A minimum of 2 diseased papillae were harvested from each sextant and, whenever available, a healthy tissue specimen was obtained from an adjacent site. After collection of the specimens, pocket elimination/reduction periodontal surgery was completed according to standard procedures. All patients received additional periodontal therapy according to their individual needs.
RNA extraction, reverse transcription, in vitro cRNA synthesis
The tissue specimens were stored in a liquid RNA stabilization reagent * overnight at 4°C, snapfrozen and stored in liquid nitrogen. All further processing occurred simultaneously for gingival biopsies originating from the same donor. Specimens were homogenized in a liquid buffer † . After incubation with chloroform and centrifugation at 12,000g, RNA collected in the upper aqueous phase was precipitated by mixing with isopropyl-alcohol and additional centrifugation and washed in 75% ethanol. The extracted RNA was purified using a total RNA isolation kit ‡ , quantitated spectrophotometrically, and 7.5 micrograms of total RNA was reverse-transcribed using a one-cycle cDNA synthesis kit § . Synthesis of biotin-Labeled cRNA was performed using appropriate amplification reagents for in vitro transcription ∥ . The cRNA yield was determined spectrophotometrically at 260 nm. The cRNA was fragmented by incubation in fragmentation buffer at 94°C for 35min and stored at -80°C until hybridizations.
Gene Chip hybridizations
Human Genome arrays ¶ were used including 54,675 probe sets to analyze more than 47,000 transcripts including 38,500 well-characterized human genes. Hybridizations, probe array scanning and gene expression analysis were performed at the Gene Chip Core Facility, Columbia University Genome Center. Each sample was hybridized once and each person contributed with 2 to 4 (median 3) samples.
Data analysis
Two statistical analyses packages were used throughout * † . Expression data were normalized and summarized using the log scale robust multi-array analysis (RMA) 22 with default settings. Differential expression was assayed using a standard mixed-effects linear model approach, with patient effects considered random with a normal distribution, and gingival tissue status considered a two-level fixed effect ("healthy" vs. "diseased"). Statistical significance for each probe set was determined using both the Bonferroni criterion and q-value. 23 For each probe set, a fold-change was computed by dividing the raw expression values among "diseased" tissue samples by the raw expression values among "healthy" samples. Therefore, fold-change values represent relative RNA levels in "disease" vs. "health".
Gene Ontology analysis was performed using ermineJ 24 with the Gene Score Resampling method. P-values were used as input to identify biologically-relevant groups of genes showing differential expression in health and disease. Gene symbols and descriptions were derived from the Gemma System (HG-U133_Plus_2_NoParents.an.zip) and downloaded from: http://www.bioinformatics.ubc.ca/microannots/.
Additional ontology analysis of all genes with a q-value of <0.05 was carried out using Pathway Express 25 in which the differentially expressed genes were mapped to the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways (http://www.genome.jp/kegg/).
Experimental details and results following the MIAME standards 26 are available at the Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE 10334.
RESULTS
The mean age of the patients was 42 years (range 13-76; Table 1 ). Based on self-reported race/ ethnicity, 37% of the patients were White, 21% Black, 32% of mixed race, and 76% Hispanic. According to the 1999 International Workshop for the Classification of Periodontal Diseases and Conditions criteria 27 , 70% of the patients had chronic and 30% aggressive periodontitis. On average, study participants had 28 teeth present, 57 sites with PD≥5 mm, 54 sites with AL≥5 mm and 71% BoP. Among the 247 harvested gingival tissue samples (183 from diseased and 64 from healthy sites), 67% had PD≥5 mm and 62% AL≥5 mm (Table 2) . No healthy gingival tissues samples were available from 26 subjects.
Transcriptome analysis revealed that 32,598 probes sets were differentially expressed between healthy and diseased tissue samples at q<0.05. Of those, 51% were up-regulated and 49% down-regulated in disease when compared to health. Applying the Bonferroni correction for 54,675 comparisons, a total of 12,744 probe sets were differentially regulated (p<9.15×10 -7 ; 5,295 up-regulated and 7,449 down-regulated in disease when compared to health). The ¶ Human Genome U-133 Plus 2.0 arrays; Affymetrix * R version 2.3.1 for Linux OS † SAS for PC version 9.1; SAS Institute, Cary, NC, USA complete list of differentially regulated probe sets can be viewed on Online (Supplemental Table 1 ).
Fold-changes in expression ranged between 5.73 and 3.89 (all p-values<1.1×10 -16 ) for the top 50 probe sets with increased expression in diseased relative to healthy tissue samples (Fig. 1A) , and between 4.35 and 2.13 (all p-values<1.1×10 -16 ) for the top 50 probe sets with decreased expression in diseased samples [inverse values of the strongest (0.23) and weakest (0.47) fold change values quoted; Fig. 1B ].
Gene ontology analysis identified 61 differentially expressed groups at p<0.05 including apoptosis, antimicrobial humoral response, antigen presentation, regulation of metabolic processes, signal transduction, and angiogenesis (Table 3) . Four selected differentially regulated pathways by Pathway Express analysis are illustrated in Fig. 2 (MAPK signaling pathway, Fig. 2A ; cytokine-cytokine receptor interaction, Fig. 2B ; cell adhesion molecules, Fig. 2C; and apoptosis, Fig. 2D ). The top 50 pathways identified by this analysis are listed in Table 4 .
DISCUSSION
To the best of our knowledge, this is the first study to systematically describe the transcriptomes of healthy and diseased gingival tissues in patients with destructive periodontal diseases. The primary aim of this report is to provide a comprehensive description that will serve as an information resource for investigators interested in the pathobiology of periodontitis. Clearly, the presented gene expression data need to be subjected to additional verification steps before their exact biological significance is fully appreciated. These may include confirmation by independent techniques on the mRNA level such as real time RT-PCR, and by proteomic analyses. Therefore, at this point, the presented data are not meant to provide unequivocal evidence for the involvement of any particular gene in the disease process, but rather to identify broad consortia of genes and pathways that are likely differentially expressed in states of gingival health and disease.
Our study has several strengths relevant to its ambition to serve as a high quality research resource. First, we have involved a relatively large sample of well-characterized, patients with periodontitis that were free of confounding exposures such as systemic disease, medications and smoking. Second, our gene expression data are generated by a large number of arrays representing strictly defined clinical conditions and multiple sites per subject. Third, our gingival tissue samples were obtained prior to any therapeutic manipulation of the gingival tissues. Lastly, by allowing direct access to our raw data, we enable independent investigators to conduct focused analyses targeting individual genes and pathways of particular interest to them.
We would like to draw attention to a number of points that will facilitate a correct interpretation of our findings: it must be realized that the reported transcriptomes represent the composite gene expression of a variety of cells that constitute and populate the healthy and diseased gingival tissues, including epithelial cells, connective tissue fibroblasts and infiltrating cells. Although the assayed tissue samples were deemed to be "diseased" or "healthy" based on accepted clinical signs of gingival inflammation the extent of the inflammatory infiltrate, the degree of vascularization and the epithelial/connective tissue content of each gingival tissue sample were unknown and likely variable. In future studies, use of cell-capture techniques may facilitate the study of homogeneous cell subpopulations, and may generate data that can be directly comparable to those stemming from well-defined in vitro systems, such as the recently reported transcriptional profiles of cultured oral epithelial cells challenged by specific periodontal pathogens and commensals 28-30 , or the in vivo regulation of specific proteins in rodent junctional and pocket epithelia. 31 With respect to the clinical status of the obtained gingival tissue samples, it must be noted that the transcriptomes of healthy and intact gingival tissues of periodontitis patients may not necessarily be identical to those of healthy sites in subjects that have not experienced destructive periodontitis. Consequently, since our data are based exclusively on a cohort of patients with periodontitis, our findings cannot identify "susceptibility genes". Furthermore, the observed heterogeneity in expression among diseased tissue samples even for genes that were, on average, undisputedly differentially regulated between health and disease may reflect varying states of disease activity among clinically homogeneous sites. There are additional potential explanations for this heterogeneity, such as differential bacterial colonization patterns across diseased sites. Future analyses from our group will incorporate data on bacterial colonization patterns and will be informative in this regard. Lastly, while a potential effect of infiltration anesthesia on gene expression is conceivable, there is little reason to expect differential anesthesia-mediated effects in diseased versus healthy samples, and thus a systematic bias in the reported comparisons.
In this first report, we will not proceed with an in-depth discussion of specific differentially regulated pathways in health and disease but will rather provide examples that underscore the utility of the expression data. At first glance, one can view the transcriptome findings as largely confirmatory of anticipated differences based on earlier histologic or biochemical analyses. For example, the vast majority of the top genes with increased expression in disease as compared to health are indeed immunoglobulin-related genes. However, genes far less readily associated with periodontitis were also observed to be least expressed in disease or, alternatively, most expressed in health (e.g. desmocollin 1, arylacetamide deacetylase-like 2, guanylate cyclase C). Likewise, the most expressed chemokine in disease (by 3.85-fold, p<10 -18 ) was CXCL6 (granulocyte chemoattractant protein 2, GCP-2), a molecule known to be involved in inflammatory bowel diseases 32 but not earlier associated with gingival inflammation. Lastly, confirming and extending recent preliminary findings 33 , our data showed that matrix metalloproteinases 7, 13, 3, 1, 9, 14, 2 and 28 and their inhibitors TIMP-3 and TIMP-2 are significantly up-regulated in diseased tissues. The above examples illustrate the utility of transcriptional data in guiding future focused studies of the pathobiology of periodontitis. Mixed 32%
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